Business Wire

MIPI Alliance Expands Reach with New Automotive Working Group


The MIPI Alliance, an international organization that develops interface specifications for mobile and mobile-influenced industries, today announced the formation of the MIPI Automotive Working Group (AWG) to address the needs of the automotive ecosystem. The group is open to MIPI Contributor members.

As the number of sensors continues to increase in the automobile to support passive and active safety, infotainment, advanced driver assistance systems (ADAS) and autonomous driving systems, the need for interface specifications is apparent. Building upon the success of the MIPI Alliance Automotive Subgroup and Automotive Birds of a Feather (BoF) Group, the MIPI Board of Directors has approved the creation of the MIPI AWG.

“The approval of the MIPI Automotive Working Group marks a significant milestone for MIPI Alliance’s development activity,” said Joel Huloux, chairman of MIPI Alliance. “While MIPI’s focus is foremost on developing interface specifications for mobile devices, automakers already rely on MIPI’s industry-standard interfaces to enable a wide variety of applications. This additional focus on automotive is a natural extension to broaden MIPI specifications’ applicability.”

The first focus of the group will be to collaborate with other MIPI working groups on a new automotive physical layer specification for longer reach applications. This work will build upon the success of MIPI Alliance’s development of high-speed physical layer specifications that serve as essential interconnection in mobile and other devices. In addition, the group will look at other existing MIPI specifications and determine their adaptability to automotive use cases.

“We look forward to working with MIPI working groups and the MIPI Auto BoF to bring together automotive ecosystem requirements to support a high-speed serial data link,” said Matt Ronning, chair of the MIPI AWG. “MIPI’s Automotive Working Group will help align key interfaces for cameras, lidars, radars, displays and more with OEMs’ specific requirements in automotive. As new MIPI interfaces are developed, while rooted in mobile, they will now also have an eye toward automotive.”

“Standardization of all interfaces between subsystems, like surround sensors, and ECUs (electronic control units) is a prerequisite of modular concepts for automotive systems,” said Uwe Beutnagel-Buchner, vice chair of the MIPI AWG. “Additionally automotive systems stand to benefit from standardized interfaces to meet development, cost, testing and reliability requirements. Highly sensitive, mission-critical automotive applications also benefit from MIPI interfaces’ low electromagnetic interference (EMI), a capability that’s been proven in billions of mobile phones and other handheld devices.”

Join the MIPI Alliance Automotive Working Group

The MIPI AWG is seeking Contributor member participants to provide key input into current and future MIPI interface specifications. The Automotive Working Group will meet through regular teleconferences, as well as face-to-face sessions at MIPI member meetings.

To learn more about the AWG, visit:

The Auto BoF will remain in place to foster communication between the AWG and the automotive ecosystem. Qualified experts from original equipment manufacturers (OEMs), tier-one suppliers, component suppliers and related are encouraged to join the existing MIPI Auto BoF, which is open to both MIPI members and nonmembers. To learn more and join the group visit:

Additionally, MIPI Alliance will host a webinar “MIPI Alliance Extends Interface Standards to Support the Automotive Market,” on April 4, 2018, at 8:00 am PDT, 11 am EDT. To register, go to:

Join MIPI at ADAS Sensors 2018

MIPI Alliance is a sponsor the 3rd Annual ADAS Sensors Conference & Exhibition on April 4-5, 2018, in Detroit, Michigan. Learn more at:

To discover more about MIPI Alliance and to connect with its social networks, follow its Twitter page, join its LinkedIn group and like its Facebook page. To join MIPI Alliance, use the Join MIPI link on the organization’s site.

About MIPI Alliance

MIPI Alliance (MIPI) develops interface specifications for mobile and mobile-influenced industries. There is at least one MIPI specification in every smartphone manufactured today. Founded in 2003, the organization has 300 member companies worldwide and 13 active working groups delivering specifications within the mobile ecosystem. Members of the organization include handset manufacturers, device OEMs, software providers, semiconductor companies, application processor developers, IP tool providers, test and test equipment companies, as well as camera, tablet and laptop manufacturers. For more information, please visit

MIPI® is a registered trademark owned by MIPI Alliance. All other trademarks cited are the property of their respective owners.

Contact information

Interprose for MIPI Alliance
Lisa McCausland, +1 303-888-2137

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28Pressemelding

Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (, a leading German electronics publication. This press release features multimedia. View the full release here: Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl

Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05Pressemelding

Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the

Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52Pressemelding

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal

CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50Pressemelding

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation

Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46Pressemelding

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c

Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00Pressemelding

Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at This press release features multimedia. View the full release here: Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on